Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Intangibles of $48.9 million for Q1 2026, down 8.64% on a QoQ basis from $53.5 million in Q4 2025, and down 28.94% year-over-year from $68.8 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Intangibles history runs 7 years deep, the most recent figure standing at $48.9 million for Q1 2026.
- Quarterly Intangibles fell 28.94% year-over-year to $48.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.9 million (down 28.94% YoY) and the FY2025 annual result came in at $53.5 million, down 26.24% from the prior year.
- Intangibles was $48.9 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $53.5 million in the prior quarter.
- Across five years, Intangibles topped out at $111.0 million in Q4 2022 and bottomed at $20.8 million in Q1 2022.
- A 5-year average of $72.6 million and a median of $72.5 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles jumped 422.04% — and 2026, when it retreated 28.94%.
- Ginkgo Bioworks Holdings' Intangibles stood at $111.0 million in 2022, then slipped by 25.49% to $82.7 million in 2023, then dropped by 12.37% to $72.5 million in 2024, then declined by 26.24% to $53.5 million in 2025, then dropped by 8.64% to $48.9 million in 2026.
- Business Quant data shows DNA's Intangibles at $48.9 million in Q1 2026, $53.5 million in Q4 2025, and $61.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | 48.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.86 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 61.52 Mn |
| Jun 30, 2025 | 66.15 Mn |
| Mar 31, 2025 | 68.76 Mn |
| Dec 31, 2024 | 72.51 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 90.60 Mn |
| Mar 31, 2024 | 77.41 Mn |
| Dec 31, 2023 | 82.74 Mn |
| Sep 30, 2023 | 100.17 Mn |
| Jun 30, 2023 | 105.03 Mn |
| Mar 31, 2023 | 108.74 Mn |
| Dec 31, 2022 | 111.04 Mn |
| Sep 30, 2022 | 47.94 Mn |
| Jun 30, 2022 | 39.18 Mn |
| Mar 31, 2022 | 20.83 Mn |
| Dec 31, 2021 | 21.64 Mn |
| Sep 30, 2021 | 22.57 Mn |
| Dec 31, 2020 | 3.29 Mn |